Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Amortizatization of Intangibles (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Amortizatization of Intangibles for 5 consecutive years, with -$103000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Amortizatization of Intangibles fell 351.22% to -$103000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was -$305000.0, a 225.51% decrease, with the full-year FY2024 number at $158000.0, up 20.61% from a year prior.
  • Amortizatization of Intangibles was -$103000.0 for Q1 2020 at Forte Biosciences, down from -$59000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $283000.0 in Q2 2016 to a low of -$285000.0 in Q3 2016.
  • A 5-year average of $705.88 and a median of $13000.0 in 2017 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: surged 4700.0% in 2018, then plummeted 542.86% in 2019.
  • Forte Biosciences' Amortizatization of Intangibles stood at $14000.0 in 2016, then dropped by 7.14% to $13000.0 in 2017, then surged by 930.77% to $134000.0 in 2018, then plummeted by 144.03% to -$59000.0 in 2019, then crashed by 74.58% to -$103000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Amortizatization of Intangibles are -$103000.0 (Q1 2020), -$59000.0 (Q4 2019), and -$124000.0 (Q3 2019).